NEW YORK (GenomeWeb News) – Transposagen Biopharmaceuticals, a privately held firm making animal models of human disease for research purposes, today said that it has been approved for a $325,000 forgivable loan from the Kentucky High-Tech Investment Pool.
Lexington, Ky.-based Transposagen said that it will use the funding to purchase lab equipment and to “obtain protection” for its intellectual property.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more